Analyst Ratings for Immunovant (IMVT) [Sells]
IMVT Rating Summary
IMVT Price Target Summary
- Highest: $30.00 (Guggenheim)
- Lowest: $18.00 (UBS)
- Average: $26.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.20 (+69%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
Avg. $ Target:
$26.20 (+69%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/2/2021 | Credit Suisse | Tiago Fauth | Downgrade | Underperform (Neutral) |
7.00 (12.00) |
10.46 (15.50) |
48.18% | Details |
